menu ☰
menu ˟

FDA draft guidance on drug compounding may limit access to affordable medications

24 Apr 2018
The FDA has introduced draft guidance that, if finalized, would expand the agency’s oversight of drug compounding and restrict the production of compounded drugs in FDA-registered outsourcing facilities.Although the guidance — which is open for p...

Click here to view the full article which appeared in Nursing

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.